Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × tipifarnib × Clear all

NCT00012350 2012-10-23

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell